XML 13 R3.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Revenues:        
Total revenues $ 135,673 $ 24,448,761 $ 2,965,579 $ 25,978,405
Operating expenses:        
Research and development 22,486,266 22,462,620 46,876,155 47,040,371
General and administrative 5,850,101 7,189,310 12,825,129 16,887,325
Total operating expenses 28,336,367 29,651,930 59,701,284 63,927,696
Loss from operations (28,200,694) (5,203,169) (56,735,705) (37,949,291)
Other income (expense):        
Interest income 755,330 518,525 1,380,864 1,083,948
Interest expense (2,194,783) 0 (2,851,031) 0
Change in fair value of common stock warrants 0 259,971 0 132,130
Gain (loss) on investment in affiliated entities (173,212) (2,092,608) (923,315) 287,815
Other income (expense), net 127,512 (121,844) 91,673 (374,744)
Net loss before income tax benefit/(provision for income tax) (29,685,847) (6,639,125) (59,037,514) (36,820,142)
Income tax benefit/(provision for income taxes) 106,771 0 169,571 (2,169,811)
Net loss (29,579,076) (6,639,125) (58,867,943) (38,989,953)
Net loss attributable to non-controlling interest 191,850 0 261,455 0
Net loss attributable to Inovio Pharmaceuticals, Inc. $ (29,387,226) $ (6,639,125) $ (58,606,488) $ (38,989,953)
Net loss per share attributable to Inovio Pharmaceuticals, Inc. stockholders        
Basic (dollars per share) $ (0.30) $ (0.07) $ (0.60) $ (0.43)
Diluted (dollars per share) $ (0.30) $ (0.08) $ (0.60) $ (0.43)
Weighted average number of common shares outstanding        
Basic (shares) 98,083,896 91,153,776 97,795,910 90,804,722
Diluted (shares) 98,083,896 91,241,660 97,795,910 90,890,792
Revenue under collaborative research and development arrangements        
Revenues:        
Total revenues $ 64,283 $ 24,385,852 $ 2,834,995 $ 25,674,898
Revenue under collaborative research and development arrangements with affiliated entities        
Revenues:        
Total revenues 71,390 60,319 126,970 208,327
Miscellaneous revenue        
Revenues:        
Total revenues $ 0 $ 2,590 $ 3,614 $ 95,180